跳至主要内容
临床试验/IRCT20170315033086N6
IRCT20170315033086N6已完成2 期

The efficacy of Inflawell capsules containing Boswellic acids in patients with cognitive impairment due to traumatic brain injury: A Randomized, Double-blind Placebo-controlled Trial

Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • traumatic brain injury patients
  • Patients who are in 3 months to 3 years from the time of traumatic brain injury

排除标准

  • Patients with uncontrollable seizures
  • Patients with impaired level of consciousness
  • Patients with (Glasgo outcome scale) GOS less than 3
  • Taking anticholinergic drugs
  • Taking anticonvulsants and sedatives drugs (such as Phenytoin, Topiramate, Levetiracetam)
  • Epidural hematoma, subdural hematoma and Contusion
  • substance abuse
  • Previous brain trauma
  • Multiple sclerosis, Bipolar mood disorder, Schizophrenia, aphasia, spinal cord injury, motor disorder
  • Lactation and pregnanacy

研究者

相似试验